Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-19-000340

CHIEF FINANCIAL OFFICER bought 6,900 shares at $3.85 ($26,565)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FARR KEVIN M CHIEF FINANCIAL OFFICER 2019-03-15 Purchase +6,900 $3.85 $26,565 36,625 D: show line 1 in the form
Open-market purchases · 6,900 sh · avg $3.85 · $26,565
Loading xslF345X03/form4-03152019_050347.xml…